Throughout the pandemic, men have consistently faced graver outcomes from COVID-19 than women, and science has long searched for the biological thread that explains this disparity. A new study from Washington University, published in JAMA Network Open, offers a surprising turn: among hospitalized men, it was not an abundance of testosterone but its absence that correlated with severity, ventilator use, intensive care, and death. The finding dismantles an early and intuitive hypothesis, replacing certainty with a more humbling question — whether low testosterone is a cause of vulnerability or m
The Indian Express
· May 26, 2021
· health
· 1 min de lectura
Medium
Verificación: Verificado
Study links low testosterone to severe Covid-19 in men
37 patients died during the study, including 25 men, with those having lowest testosterone levels at highest mortality risk.
◉
Health & Medicine
8412 artículos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% coincidencia
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% coincidencia
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% coincidencia
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% coincidencia
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% coincidencia
Cobertura Relacionada
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Medical research on COVID-19 severity has no geopolitical implications; this is a public health study without international relations, strategic, or power dynamics relevance.
Escalation Risk
N/A
Confidence
HIGH
Lente Económico
📈
Study links low testosterone to severe COVID-19 in men, with potential implications for healthcare costs, pharmaceutical demand, and insurance risk assessment, though causation remains unproven.
Market Signal
neutral
Confidence
LOW
Healthcare and Pharmaceuticals
Medical Diagnostics and Testing
Health Insurance
Biotechnology and Research
Hospital Services
If validated, findings could drive increased testosterone screening and hormone replacement therapy demand among male COVID-19 patients and at-risk populations, potentially increasing out-of-pocket healthcare costs. May also influence insurance premiums and coverage decisions based on hormone levels.
Potential regulatory pathways for testosterone screening protocols in COVID-19 treatment guidelines; possible insurance coverage expansion for hormone testing; increased R&D funding for hormone-based COVID-19 interventions; occupational health policies for high-risk male workers. Requires further validation before policy implementation.